-
-
表 1 各时间点甲状腺功能指标数据
Table 1. Thyroid function data of case 1 in different time points
-
[1] Fallahi P, Ferrari SM, Vita R, et al. Thyroid dysfunctions induced by tyrosine kinase inhibitors[J]. Expert Opin Drug Saf, 2014, 13(6):723-733. https://www.researchgate.net/publication/262574594_Thyroid... [2] Li J, Qin S, Xu J, et al. Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase-trial[J]. J Clin Oncol, 2013, 31(26):3219-3225. doi: 10.1200/JCO.2013.48.8585 [3] Ahmadieh H, Salti I. Tyrosine kinase inhibitors induced thyroid dysfunction: a review of its incidence, pathophysiology, clinical relevance, and treatment[J]. Biomed Res Int, 2013, 2013(1):725410. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824811/ [4] Bailey EB, Tantravahi SK, Poole A, et al. Correlation of degree of hypothyroidism with survival outcomes in patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor receptor tyrosine kinase inhibitors[J]. Clin Genitourin Cancer, 2015, 13(3):e131-137. doi: 10.1016/j.clgc.2014.11.002 [5] Yimaer W, Abudouyimu A, Ye T, et al. Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in the treatment of advanced thyroid cancer: a meta-analysis of randomized controlled trials[J]. Oncol Targets Ther, 2016, (9):1167-1173. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789842/ [6] Brown RL. Tyrosine kinase inhibitor-induced hypothyroidism: incidence, etiology, and management[J]. Target Oncol, 2011, 6(4):217-226. doi: 10.1007/s11523-011-0197-2 -
点击查看大图
表(2)
计量
- 文章访问数: 104
- HTML全文浏览量: 45
- PDF下载量: 1
- 被引次数: 0
下载:
